Systematic Review of Comparative Patient Reported Outcomes and Health-Related Quality of Life after Management of Localized Renal Masses or Renal Cell Carcinomas

Laura Sandbergen, Muhammad Imran Omar, Lavin Othman, Faridi van Etten-Jamaludin, Mustafa Soytas, Jean J. De La Rosette, M. Pilar Laguna* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Downloads (Pure)


Objective: To perform a systematic review assessing the impact of the different management options on health-related quality of life (HRQoL) of patients with localized renal masses or renal cell carcinomas (LRM/LRCC).

Materials and Methods: Searches covering PubMed, Embase (Ovid), CENTRAL, PsycINFO (Ovid), CINAHL (EBSCO), and Cochrane Central Register of Controlled Trials (CENTRAL) databases was conducted for papers published up to 25 April 2021. Methods as per Cochrane Handbook were followed. “Modality” of treatment included radical nephrectomy (RN), nephron-sparing surgery (NSS), thermal ablation (TA), and active surveillance (AS). “Approach” was categorized as open incision and minimally invasive surgery (MIS). Risk of bias was assessed by ROBINS-I and Cochrane RoB 2 for observational studies and randomized controlled trials, respectively and certainty of the evidence by GRADE.

Results: Sixteen observational studies and 1 randomized controlled trial (2.370 patients) met inclusion criteria. Fifteen different patient reported outcome measures (PROMs) were identified. Heterogeneity prevented quantitative analysis.

Generic HRQoL decreases after RN and NSS, recovers within 6 to 12 months, and mostly overlaps with baseline values, irrespective of modality. Cancer-specific HRQoL improve faster after open-NSS than open-RN. The detrimental effect of RN may persist long-term in cross-evaluations. QoL scales significantly decrease after open surgery and MIS during the first weeks but improve faster after MIS. They are similar for both approaches at 1-year. Long-term cancer-specific QoL is similar for MIS and open procedures. Fear of recurrence is lower in older patients and affected by neither modality nor approach.

Conclusions: Low quality evidence supports the use of MIS over the open approach when HRQoL is considered in the management of LRMs/LRCCs; data regarding the effect of the treatment modality of the LRM/LRCC show contradictory outcomes.
Original languageEnglish
Pages (from-to)209–239
Number of pages31
JournalSociété Internationale d’Urologie Journal
Issue number4
Early online date14 Jul 2022
Publication statusPublished - 14 Jul 2022

Bibliographical note

Funding: L.S. received funding from Cure for Cancer
Acknowledgements: We would like to thank Professor Christian Beisland (Norway) and Professor Abhay Rane (United Kingdom) for responding to our queries on their studies.


  • HRQoL
  • QoL
  • localized renal cell carcinoma
  • surgical management
  • localized renal mass


Dive into the research topics of 'Systematic Review of Comparative Patient Reported Outcomes and Health-Related Quality of Life after Management of Localized Renal Masses or Renal Cell Carcinomas'. Together they form a unique fingerprint.

Cite this